AIMM Therapeutics
Amsterdam · Founded 2004
About AIMM Therapeutics
production of monoclonal antibodies by immortalisation of B cells from elite patients.
Company Facts
- Founded: 2004
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Jun 2009)
- Website: aimmtherapeutics.com
- Phone: 31 205 66 50 56
Social Profiles
Canonical: https://fsome.com/organization/aimm-therapeutics-8439022 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.